MATClinics

MATClinics

Services:
External Source of Medications Used for Alcohol Use Disorder Treatment
• In-network prescribing entity

Facility Vaping Policy

• Vaping permitted without restriction

Gender Accepted

• Male
• Female

Special Programs/Groups Offered

• Clients with HIV or AIDS
• Active duty military
• Criminal justice (other than DUI/DWI)/Forensic clients
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Adult women
• Young adults
• Clients who have experienced intimate partner violence, domestic violence
• Clients with co-occurring pain and substance use disorders
• Clients who have experienced trauma
• Seniors or older adults
• Adult men
• Members of military families
• Clients with co-occurring mental and substance use disorders
• Clients who have experienced sexual abuse
• Pregnant/postpartum women
• Veterans

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Intensive outpatient treatment
• Regular outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient

Assessment/Pre-treatment

• Comprehensive substance use assessment
• Outreach to persons in the community
• Screening for substance use
• Comprehensive mental health assessment
• Screening for mental disorders
• Screening for tobacco use

Language Services

• Spanish

Ancillary Services

• Social skills development
• Case management service
• Mental health services

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Transitional Services

• Discharge Planning
• Naloxone and overdose education

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Age Groups Accepted

• Young Adults
• Adults

Testing

• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing
• Drug and alcohol oral fluid testing

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Medicare
• Private health insurance
• Medicaid

License/Certification/Accreditation

• State mental health department
• State Substance use treatment agency
• State department of health
• Commission on Accreditation of Rehabilitation Facilities (CARF)

Type of Opioid Treatment

• Prescribes naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Relapse prevention with naltrexone
• Buprenorphine maintenance
• Prescribes buprenorphine

Pharmacotherapies

• Buprenorphine (extended-release, injectable)
• Buprenorphine without naloxone
• Non-nicotine smoking/tobacco cessation
• Naltrexone (oral)
• Medication for mental disorders
• Acamprosate (Campral®)
• Buprenorphine with naloxone
• Disulfiram
• Naltrexone (extended-release, injectable)
• Nicotine replacement

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Treatment Approaches

• Cognitive behavioral therapy
• Brief intervention
• Substance use disorder counseling
• Telemedicine/telehealth therapy
• Contingency management/motivational incentives
• Motivational interviewing
• Relapse prevention
• Trauma-related counseling

Recovery Support Services

• Housing services
• Assistance with obtaining social services

Facility Smoking Policy

• Smoking permitted without restriction

Education and Counseling Services

• Group counseling
• Substance use disorder education
• Smoking/vaping/tobacco cessation counseling
• Individual counseling